漢邦高科(300449.SZ):公司工商銀行北京蘇州橋支行賬户已解除凍結
格隆匯11月20日丨漢邦高科(300449.SZ)公佈,公司於2019年11月18日披露了《關於公司個別銀行賬户被凍結暨已申請解凍的公告》,公司在中國工商銀行股份有限公司北京蘇州橋支行開立的賬户因買賣合同糾紛事宜被杭州市濱江區人民法院凍結。
經公司與交易對方協商溝通,2019年11月20日杭州市濱江區人民法院已將公司中國工商銀行股份有限公司北京蘇州橋支行賬户解除凍結。此次公司銀行賬户被凍結時間較短,公司的日常經營管理未受到重大影響。公司正積極與相關方面協商溝通,依法採取相應措施保護公司合法權益,妥善處理上述事項,並按照法律、法規及時履行相應的信息披露義務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.